Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Tigecycline, a first-in-class broad-spectrum glycylcycline antibiotic, has broad-spectrum in vitro activity against bacteria commonly encountered in complicated intra-abdominal infections (cIAIs), including aerobic and facultative Gr...
Main Authors: | Chen Xiaoping, Quan Zhiwei, Yan Lunan, Li Rong, Bi Jianwei, Leng Xisheng, Wei Junming, Zhang Yingyuan, Wu Jufang, Chen Zhangjing, Yu Yunsong, Wu Zhiyong, Liu Dawei, Ma Xiaochun, Maroko Robert, Cooper Angel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/10/217 |
Similar Items
-
Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplantation
by: C Kani, et al.
Published: (2005-06-01) -
Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplan¬tation
by: Kani C., et al.
Published: (2005-07-01) -
Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin.
by: Maria Agudelo, et al.
Published: (2019-01-01) -
A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China
by: Chen Y, et al.
Published: (2018-11-01) -
The Pattern of Imipenem/Cilastatin Administration in
Imam Khomeini Hospital (Ardabil) in 2018
by: Moien Zakavati, et al.
Published: (2019-04-01)